JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

[Children and adolescents with Down syndrome. Continuous ophthalmological monitoring crucial!].

Läkartidningen 2002 January 11
Children with Down's syndrome are at increased risk of ocular manifestations, which is confirmed by a study in Uppsala, Sweden. Sixty percent of the children were wearing glasses and/or had other ocular problems. However, lapses were found in follow-up and referral to the eye clinic. Good visual function is an important prerequisite for optimal quality of life of children and adults with Down's syndrome. Since this group does not always spontaneously get in touch with the health care system including ophthalmologists, the infant must be referred by the pediatrician immediately after birth. The number of individuals with Down's syndrome in Sweden is large (3,500-5,000), and an ophthalmological follow-up program, as presented in this paper, is of key importance.

Full text links

Management of Latent Tuberculosis Infection.JAMA 2023 January 20
Misdiagnosis in the Emergency Department: Time for a System Solution.JAMA 2023 January 28

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app